Lumbar Erector Spinae Plane Block for Back Surgery
Status:
Recruiting
Trial end date:
2021-12-15
Target enrollment:
Participant gender:
Summary
Title:
A prospective randomized double blind trial of the efficacy of a bilateral lumbar erector
spinae block on the 24 h morphine consumption after posterior lumbar interbody fusion
surgery.
Objectives:
The primary objective is to study the influence of a bilateral erector spinae block on 24h
morphine consumption.
Endpoint:
The primary endpoint is the 24 h morphine consumption in mg. Secondary endpoints are
intraoperative sufentanil requirement, total morphine during first 72 postoperative hours,
NRS pain scores in rest and defined movement (moving to chair) at regular time intervals and
Quality of Recovery 40 score (QoR-40) at fixed time intervals day 1 and 3 postoperatively
Population:
Patients undergoing posterior lumbar interbody fusion ranging 1 - 3 levels Phase 3
Number of sites Enrolling participants:
University Hospital Antwerp &AZ KLINA Brasschaat
Description of study agent:
Bilateral erector spinae block: each block contains 20 ml levobupivacaine 0.25% + 5 mcg/ml
epinephrine Study duration Until the required study population is met Participant duration 72
hours